Deal facts
- Buyer
- TULIP UK BIDCO LIMITED
- Target
- Spire Healthcare Group plc
- Deal value
- GBP 1,026,500,000
- Announced
- 7 September 2026
- Status
- Firm intention
- Sector
- Healthcare
- Country
- United Kingdom
- Consideration
- cash, loan-note
Sources
TULIP UK BIDCO LIMITED has agreed to acquire Spire Healthcare Group plc in a going private transaction valued at approximately GBP 1.0265 billion. The deal structure involves consideration comprising cash and loan notes, reflecting the equity value of the target company. This acquisition marks a significant shift for the healthcare sector entity, as it moves from public ownership to being taken private by the acquiring vehicle. The announcement was made on 7 September 2026, establishing the timeline for this major corporate restructuring event within the British market.
The transaction is currently at the firm intention stage, indicating that definitive agreements have been reached but final completion has not yet occurred. As a result, the deal remains subject to various customary closing conditions and regulatory approvals before it can be formally concluded. Spire Healthcare Group plc operates within the healthcare industry, providing private medical services across the United Kingdom. The buyer, TULIP UK BIDCO LIMITED, is based in Great Britain, aligning with the target’s domestic operations. This move effectively removes the listed company from public markets, allowing for a new ownership structure focused on long-term strategic development without the pressures of quarterly public reporting requirements.
The archive tags include a loan note. Compare completion cash, deferred payments and earn-outs before treating a headline amount as proceeds. Check the underlying announcement for the actual conditions; tags are not a complete payment schedule.
Deal timeline
1 update- Court sanction
Recommended Offer for Spire Healthcare Group plc
FOR IMMEDIATE RELEASE 5 September 2026 RECOMMENDED ACQUISITION of SPIRE HEALTHCARE GROUP PLC by TULIP UK BIDCO LIMITED (a newly formed company to be indirectly owned by a consortium including (i) funds managed or advised by Toscafund Asset Management LLP; (ii) funds managed or advised by THCP Advisory Limited; and (iii) funds managed or advised by Ares Management Limited) t
LSE RNS
For business owners
What would selling your own business involve?
Use the deal as a starting point, not a valuation benchmark. Learn the decisions behind a sale and apply them to your own preparation.
Guides are free to read. Free tools require email access; indicative results are not professional advice.
Explore
Browse adjacent archives
Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.
Similar deals
Similar deals
Other Healthcare M&A activity tracked by Exit Mode.
Merck KGaA, Darmstadt, Germany to acquire Rapid Micro Biosystems, Inc.
Merck KGaA, Darmstadt, Germany has agreed to acquire Rapid Micro Biosystems, Inc. (Nasdaq: RPID) for cash. The Agreement and Plan of Merger was signed on November 16, 20…
- Buyer
- Merck KGaA, Darmstadt, Germany
- Target
- Rapid Micro Biosystems, Inc.
- Deal value
- Not disclosed
- Deal type
- going private
Rosemont Pharmaceuticals Holdings, Inc. to acquire Aytu BioPharma Inc.
Aytu BioPharma Inc., a Nasdaq-listed Delaware company, agreed on November 16, 2026 to be acquired by Rosemont Pharmaceuticals Holdings, Inc. The two signed an Agreement…
- Buyer
- Rosemont Pharmaceuticals Holdings, Inc.
- Target
- Aytu BioPharma Inc.
- Deal value
- Not disclosed
- Deal type
- going private
Merck KGaA, Darmstadt, Germany to acquire Silence Therapeutics plc
Merck KGaA, based in Darmstadt, Germany, has agreed to acquire Silence Therapeutics plc in a cash deal that will take the healthcare company private. The transaction, an…
- Buyer
- Merck KGaA, Darmstadt, Germany
- Target
- Silence Therapeutics plc
- Deal value
- Not disclosed
- Deal type
- going private
ArcheNova Technology Co., Ltd to acquire ArcheNova Biotech Corp.
ArcheNova Technology Co., Ltd has agreed to acquire ArcheNova Biotech Corp. in a transaction valued at two billion US dollars. The deal, announced on 13 October 2026, in…
- Buyer
- ArcheNova Technology Co., Ltd
- Target
- ArcheNova Biotech Corp.
- Deal value
- USD 2,000,000,000
- Deal type
- going private
Onyx Bidco LLC to acquire Option Care Health, Inc.
Option Care Health, Inc. entered into an Agreement and Plan of Merger on October 5, 2026 with Onyx Bidco LLC and its wholly owned subsidiary Onyx Merger Sub, Inc., both…
- Buyer
- Onyx Bidco LLC
- Target
- Option Care Health, Inc.
- Deal value
- Not disclosed
- Deal type
- going private
Buyer history
TULIP UK BIDCO LIMITED
See every published Exit Mode archive entry where this buyer appears.
View buyer profileMethodology
How this page is built
Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.
Back to the archive